Imagine telling a patient suffering from age-related (type-II) osteoporosis that a single injection of stem cells could restore their normal bone structure. This week, with a publication in STEM CELLS Translational Medicine, a group of researchers from the University of Toronto and The Ottawa Hospital suggest that this scenario may not be too far away.
Osteoporosis affects over 200M people worldwide and, unlike post-menopausal (type-I) osteoporosis, both women and men are equally susceptible to developing the age-related (type-II) form of this chronic disease. With age-related osteoporosis, the inner structure of the bone diminishes, leaving the bone thinner, less dense, and losing its function. The disease is responsible for an estimated 8.9 M fractures per year worldwide. Fractures of the hip—one of the most common breaks for those suffering from type-II osteoporosis—lead to a significant lack of mobility and, for some, can be deadly.
But how can an injection of stem cells reverse the ravages of age in the bones?
Professor William Stanford, senior author of the study, had in previous research demonstrated a causal effect between mice that developed age-related osteoporosis and low or defective mesenchymal stem cells (MSCs) in these animals.
“We reasoned that if defective MSCs are responsible for osteoporosis, transplantation of healthy MSCs should be able to prevent or treat osteoporosis,” said Stanford, who is a Senior Scientist at The Ottawa Hospital and Professor at the University of Ottawa.
To test that theory, the researchers injected osteoporotic mice with MSCs from healthy mice. Stem cells are “progenitor” cells, capable of dividing and changing into all the different cell types in the body. Able to become bone cells, MSCs have a second unique feature, ideal for the development of human therapies: these stem cells can be transplanted from one person to another without the need for matching (needed for blood transfusions, for instance) and without being rejected.
After six months post-injection, a quarter of the life span of these animals, the osteoporotic bone had astonishingly given way to healthy, functional bone.
“We had hoped for a general increase in bone health,” said John E. Davies, Professor at the Faculty of Dentistry and the Institute of Biomaterials & Biomedical Engineering (IBBME) at the University of Toronto, and a co-author of the study. “But the huge surprise was to find that the exquisite inner “coral-like” architecture of the bone structure of the injected animals—which is severely compromised in osteoporosis—was restored to normal.”
The study could soon give rise to a whole new paradigm for treating or even indefinitely postponing the onset of osteoporosis. Currently there is only one commercially available therapy for type-II osteoporosis, a drug that maintains its effectiveness for just two years.
And, while there are no human stem cell trials looking at a systemic treatment for osteoporosis, the long-range results of the study point to the possibility that as little as one dose of stem cells might offer long-term relief.
“It’s very exciting,” said Dr. Jeff Kiernan, first author of the study. A graduate from IBBME who is beginning a Postdoctoral Fellowship at The Ottawa Hospital with the Centre for Transfusion Research, Kiernan pursued the research for his doctoral degree.
“We’re currently conducting ancillary trials with a research group in the U.S., where elderly patients have been injected with MSCs to study various outcomes. We’ll be able to look at those blood samples for biological markers of bone growth and bone reabsorption,” he added.
If improvements to bone health are observed in these ancillary trials, according to Stanford, larger dedicated trials could follow within the next 5 years.
The Latest on: Age-related osteoporosis
via Google News
The Latest on: Age-related osteoporosis
- Guest commentary: Help battle osteoporosis, the 'silent thief'on May 19, 2022 at 7:30 pm
Known as the “silent thief,” osteoporosis is a disease that thins and weakens bones to the point where they break easily. Most people don’t know they have a problem until ...
- Opinion: Don’t Neglect Bone Healthon May 19, 2022 at 3:23 am
Half of women, and up to 25 percent of men, age 50 and older will experience a fracture in their lifetimes – but most relegate bone health to the bottom of age-related wellness concerns. May is ...
- If You’re Looking for a Bone-Building Workout, an MD Recommends Making This Surprising Tweak to Your Walkson May 18, 2022 at 8:00 am
Going on regular hot girl walks (aka long leisurely strolls) is one way to prevent weakness. In a 1994 study in The American Journal of Medicine, researchers found that women who walk more than 7.5 ...
- Abaloparatide Works in 'Ignored Population': Men With Osteoporosison May 16, 2022 at 8:20 am
men account for approximately 30% of the societal burden of osteoporosis and have greater fracture-related morbidity and mortality than women. About one in four men over the age of 50 years will have ...
- Wear a White Ribbon for Osteoporosis Awarenesson May 16, 2022 at 3:00 am
The Bone Health and Osteoporosis Foundation has designated May as National Osteoporosis Awareness and Prevention Month. It may surprise you to know that fractures related to osteoporosis account for m ...
- Improvement in Health-related Quality of Life in Osteoporosis Patients Treated With Teriparatideon May 15, 2022 at 5:00 pm
Background: Individuals with osteoporosis and recent vertebral fractures suffer from pain and impaired health-related quality of ... The mean age was 63.8 years (standard deviation 12.1 years).
- Tymlos Boosts Bone Health in Men With Osteoporosison May 14, 2022 at 8:06 am
Treatment with abaloparatide (Tymlos) was safe and effective for men with osteoporosis, according to the phase III ATOM trial. Compared with a 1.2% increase with placebo, men randomized to receive 80 ...
- At 5.3% CAGR, musculoskeletal diseases treatment market is estimated to be worth US$ 5,730.8 million by 2025, says The Insight Partnerson May 9, 2022 at 10:24 pm
According to The Insight Partners’ research, the global musculoskeletal diseases treatment market generated US$ 3,837.9 million in 2017 and is estimated ...
- How to increase bone densityon May 9, 2022 at 2:37 pm
Nutrition consultant Jenna Hope says: “Maintaining high bone density is essential in reducing the risk of age-related bone disorders, such as osteoporosis, which occurs when bones become weak ...
- Jane Fonda health: 'I hurt a lot' - star, 84, on her 'genetic' osteoporosison April 26, 2022 at 1:28 am
hormone-related conditions, or malabsorption problems A family history of osteoporosis – particularly a hip fracture in a parent Long-term use of certain medicines that can affect bone strength ...
via Bing News